Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Recursion Pharmaceuticals, Inc. RXRX is a “terrific spec” and he recommended buying the same. On May 9, Recursion Pharmaceuticals reported better-than-expected first-quarter financial results. …